These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12955427)

  • 41. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
    Sawhney N; Moses JW; Leon MB; Kuntz RE; Popma JJ; Bachinsky W; Bass T; DeMaio S; Fry E; Holmes DR; Teirstein PS
    Circulation; 2004 Jul; 110(4):374-9. PubMed ID: 15249503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of bifurcation lesions using dedicated bifurcation stents versus classic bare-metal stents. Randomized, controlled trial with 12-month angiographic follow up.
    Cervinka P; Bystron M; Spacek R; Kvasnak M; Adhikari S; Jakabcin J
    J Invasive Cardiol; 2008 Oct; 20(10):516-20. PubMed ID: 18829995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study.
    Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A;
    Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
    Akbulut M; Ozbay Y; Karaca I; Ilkay E; Gundogdu O; Arslan N
    Coron Artery Dis; 2004 Sep; 15(6):347-52. PubMed ID: 15346093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
    JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial).
    Bernardi V; Szarfer J; Summay G; Mendiz O; Sarmiento R; Alemparte MR; Gabay J; Berger PB
    Am J Cardiol; 2007 Feb; 99(3):349-52. PubMed ID: 17261396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy.
    Radke PW; Kobella S; Kaiser A; Franke A; Schubert D; Grube E; Hanrath P; Hoffmann R
    Eur Heart J; 2004 Jun; 25(11):920-5. PubMed ID: 15172463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.
    Kuchulakanti P; Torguson R; Canos D; Satler LF; Suddath W; Chan R; White LR; Gevorkian N; Bui A; Wang B; Kent KM; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2005; 6(3):108-12. PubMed ID: 16275606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
    Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasound.
    Hall P; Nakamura S; Maiello L; Almagor Y; Gaglione A; Goldberg SL; Tobis JM; Martini G; Tucci G; Di Maggio M
    J Invasive Cardiol; 1995; 7 Suppl A():12A-22A. PubMed ID: 10155111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Angiographic follow-up of 293 patients receiving placement of long coronary stents with different diameters].
    Huang Z; Shigeru N; Osamu K
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1419-21. PubMed ID: 18753075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
    Oemrawsingh PV; Tuinenburg JC; Schalij MJ; Jukema JW; Reiber JH; Bruschke AV
    Am J Cardiol; 1998 Jan; 81(2):152-7. PubMed ID: 9591897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracoronary stent implantation under intracoronary ultrasound guidance with aspirin and ticlopidine therapy.
    Zhang D; Cai X; Shen W; Schiele F; Bassand JP
    Chin Med J (Engl); 2001 Mar; 114(3):262-5. PubMed ID: 11780310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.